Christina Applegate recently revealed a misdiagnosis of multiple sclerosis (MS), raising questions about the confusion surrounding the disease and closely related conditions. The 54-year-old actress discussed her experiences on the Oct. 20 episode of her podcast, “MeSsy”, alongside co-host Jamie-Lynn Sigler, describing her state as one of being in shock.
Applegate’s initial diagnosis came in 2021, alongside symptoms leading to consultations and tests like brain and spinal MRIs, which revealed numerous lesions.
“And my B cells didn’t change. They didn’t go higher, they didn’t go lower, they didn’t change, and she had never seen that,” Applegate shared. “So I guess that began kind of a study into my diagnosis.”
Eventually, a further investigation determined she did not have MS, a conclusion offered by her neurologist after observing a previously unnoticed feature.
Understanding MS Misdiagnosis
Dr. Marwa Kaisey, an associate professor of neurology at Cedars-Sinai in Los Angeles, emphasized that misdiagnosis is not unusual. A study at MS clinics in UCLA and Cedars-Sinai revealed nearly one in five patients diagnosing with MS were incorrect.
The lack of a single conclusive test for MS complicates diagnoses. Criteria for diagnosing MS include a series of subjective observations.
New Findings in Brain Scans
While lesions on MRI scans are common among misdiagnosed patients, the central vein sign—a characteristic associated with MS—has been incorporated to help distinguish true MS indicators from other causes.
Dr. Richard Ransohoff highlighted the importance of the central vein sign as an advancement in identifying MS, emphasizing the improvements in diagnostic capabilities since Applegate’s symptoms began.
Ransohoff and Kaisey noted that MS symptoms, such as tingling and fatigue, share similarities with other disorders, challenging accurate diagnosis further.
Dealing with Misdiagnoses
Kaisey suggested seeking second opinions and remaining open to new evaluations to prevent misdiagnosis.
Ransohoff added that many conditions share patterns with MS, including strokes, neuromyelitis optica spectrum disease, and lupus. Among common alternatives, migraines may produce MRI abnormalities similar to those found in MS cases.
“Facing the unknown when you feel crappy is a very tough road to go,” Kaisey noted.
Ransohoff suggested patients with an MS diagnosis consult specialists to confirm and explore targeted treatment plans.
Progress in MS Treatment
Ransohoff stated that options for MS treatment have increased significantly over time, transforming patient outlooks and outcomes.
With over 20 medications available today, working with experienced specialists ensures personalized treatment plans, maximizing potential quality of life improvements for those correctly diagnosed.
